JSAUX Kicks Off Black Friday Event with Major Savings on Gaming Accessories
HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Tech manufacturer JSAUX has initiated its annual Black Friday promotion , offering discounts on various gaming peripherals and accessories. The sale is available through both the company's official website...
First Flock of 19 Whooper Swans Arrives in Rongcheng for Winter
WEIHAI, China, Nov. 3, 2025 /PRNewswire/ -- A news report from CRI Online: The first flock of 19 whooper swans has been spotted at Rongcheng Swan Lake, marking the official start of the swan season in the coastal city. Staff at the Rongcheng...
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated...
MetaOptics Announces Strategic Expansion into the USA with Nevada Incorporation and Advanced 127μm Co-Packaged Optics Breakthrough
SINGAPORE, Oct. 29, 2025 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics"), a leading-edge semiconductor optics company pioneering metalens technology, is pleased to announce the establishment of its United States entity, MetaOptics Inc....
BioDlink Completes First International Shipment of Bevacizumab to Colombia
Bevacizumab is a targeted therapy used to treat lung and colorectal cancers, both among the top three cancers ranked by death in Colombia[1]. This inaugural shipment—dispatched around two months after Colombia's marketing approval—demonstrates the...
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, Results from a Phase 3 study of...
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key...
Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
CHENGDU, China, Oct. 17, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab botidotin...
Turfan, Xinjiang: Electricity Ensures Steady Development of a 3-Billion-Yuan Energy Hub
TURFAN, China, June 24, 2025 /PRNewswire/ -- On June 24, the temporary construction phase of the No. 1 Open-Pit Mine in the Kumtag Mining Area, located in Shanshan County, Turfan City, Xinjiang, officially commenced. This marks the entry of this key...
Forum held to promote cooperation between China, Central Asia news agencies
ASTANA, Kazakhstan, June 24, 2025 /PRNewswire/ -- This is a report from Xinhuanet: President of Xinhua News Agency Fu Hua attends the China-Central Asia News Agency Forum in Astana, Kazakhstan, June 22, 2025. The China-Central Asia News Agency Forum...